Cytodyn Inc (CYDY)

[Longtimelong]

I just don’t understand why anyone thinks the LH trial will produce any good results for LL. It seems to me that it will be much harder to demonstrate efficacy in LHers than in MM CD10. Science knows next to nothing about LH syndrome and what causes it, other than it likely is caused by effects of Covid. Ferreting out which symptoms of LH syndrome LL may affect will be difficult and a long, expensive multilevel trial process. CYDY can’t possibly show efficacy in a broad even 500 person trial. It’s an interesting trial and trials like it are needed, but this is something for BP, not a small biotech. The 50 ppl trial is not likely to answer anything and the next larger trial will not be a success. That puts us 12 months down the rode trying to tease out a segment of the Phase 2 that would define a Phase 3 LH trial. We better have something else going on, something that produces revenue.

“All the news just repeats itself, like some bad dream, that we’ve both seen.” J.Prine